Cardiovascular imaging startup Raywatt raises $9.9M in Series B funding led by Intervest and Life Asset Management, targeting FDA clearance and 2028 listing.
Amount Raised
$9.9 Million
Round Type
Series B
Investors
Description
Raywatt, a cardiovascular imaging diagnostics company, has closed a Series B round of $9.9 million. The funding was led by Intervest, Life Asset Management, and seven other investors including Hyundai Technology Investment and L&S Venture Capital. The company's flagship product, FASTER OCT, is an advanced optical coherence tomography system currently undergoing FDA 510(k) review. Raywatt plans to use the capital to expand globally and achieve its 2028 listing target.
Quick answer
Raywatt raised $9.9 Million in a Series B round, dated November 16, 2026. Investors: Kaic To Ventures, EcoPro Partners, Eugene Investment & Securities, L&S Venture Capital, Hyundai Technology Investment, Yookyung Psg Asset Management, LIFE Asset Management and Intervest. Raywatt is based in South Korea.
- How much did Raywatt raise?
- Raywatt raised $9.9 Million in a Series B round on November 16, 2026.
- Who invested in Raywatt?
- Kaic To Ventures, EcoPro Partners, Eugene Investment & Securities, L&S Venture Capital, Hyundai Technology Investment, Yookyung Psg Asset Management, LIFE Asset Management and Intervest are named as investors in this round.
- What does Raywatt do?
- Raywatt is a cardiovascular imaging diagnostics company that develops optical coherence tomography (OCT) systems for real-time, high-resolution imaging of heart and brain blood vessels.
- Where is Raywatt based and how big is it?
- Raywatt is based in South Korea.
Source: Fundz verified event record.
Who else raised in Medical Device and Health Diagnostics around the same time
Companies in the same sectors as Raywatt that raised within 45 days of this round, from Fundz verified event records.
- Mosaic Intelligence Labs raised $47M (Seed) on November 10, 2026.
- Laza Medical raised $160M (Series B) on November 4, 2026.
- Picard Medical raised $1.2M (Funding Round) on November 3, 2026.
- Blue Arbor Technologies raised $11M (Series A) on October 28, 2026.
- Coherence Neuro raised $45M (Series A) on October 22, 2026.
- MedEnvision raised an undisclosed amount on October 22, 2026.
Who to call at Raywatt, and when
A new round usually means Raywatt is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Raywatt raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Raywatt, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Raywatt. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Raywatt raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansRaywatt raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.